BioSpace News Archive

CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the “Company”), plans to release its results for the quarter and year ended December 31, 2018, on Wednesday, March 13, 2019 after market close.

TEACH has expanded to the University of California, Berkeley with modules being conducted at Kaiser Permanente as well as UCSF Benioff Children’s Hospital Oakland.

Brammer is a sponsor and will participate in the MassBio Forum event in Boston, MA.

Integration will increase access for SMBs to take advantage of plans offered by the leading insurance provider

Phase 1/2 Clinical Study Evaluating the Safety and Efficacy of Fresh Frozen Plasma (GMFFP) from young healthy donors ages 18 to 35, who have received Granulocyte

CLS Holdings USA Inc. (OTCQB:CLSH) (CSE:CLSH.U) “CLS”, a diversified cannabis company operating as Cannabis Life Sciences, has redeemed all of its convertible debentures issued to YA II PN, Ltd., “Yorkville”, a Cayman Island exempted limited partnership, which were issued on May 14, 2018 and July 20, 2018.

Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology therapeutics company, taking a precision medicine approach to develop drugs that target cell division (mitosis) for the treatment of leukemias, lymphomas and solid tumor cancers, today announced that two abstracts, highlighting data from the Company’s lead clinical programs of onvansertib in Acute Myeloid Leukemia (AML) and metastatic Castration-Resistant Prostate

SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced that the Company will present new in vivo data supporting the potential use of oral ibrexafungerp

StemoniX® Inc., a biotech company revolutionizing how new medicines are discovered, announced today that it has secured $14.4 million USD in Series B funding from a group of institutional and private investors

SES Connect to Streamline Communications for All Providers